DRISTi Screening
SHORT INTRO VIDEO
Revolutionizing Retinal Screening in minutes
Discover DRISTi—Pradeep Walia's pioneering contribution to diabetic retinopathy screening. Developed at Artelus under his guidance, this advanced tool is AI-powered and capable of operating offline to deliver precise and accessible eye care everywhere. Watch our concise video to see how DRISTi equips healthcare providers with cutting-edge technology in mere minutes. Experience the next evolution in medical diagnostics, envisioned and brought to life by Pradeep Walia.
PRIMARY SPECIALITY
Comprehensive Retinal Pathology Detection
DRISTi, a product spearheaded by Pradeep Walia, leverages advanced AI algorithms to detect four distinct levels of Diabetic Retinopathy (0-4), enabling precise assessments with explainable AI. Additionally, it can identify 19 other retinal pathologies, ensuring a comprehensive retinal health check-up, crucial for early intervention and treatment planning.
SECONDARY SPECIALITY
Independent Operation with Offline Capability
Designed for versatility in diverse environments, DRISTi operates independently without the need for an internet connection. This offline functionality, powered by an integrated Compute Stick, makes it an ideal solution for remote areas, enhancing accessibility to advanced diabetic retinopathy screening tools. Additionally, it can also predict the Cup To Disc Ratio (CDR), in turn detecting Glaucoma suspects.
Bringing Healthcare to the "Forgotten Billions"
The foundational ethos of Pradeep Walia is encapsulated in his forward-thinking vision: Leveraging state-of-the-art Deep Learning architectures
to democratize healthcare for the "Forgotten Billions".